Processa Pharmaceuticals, Inc. (PCSA) NASDAQ
2.61
+0(-1.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.61
+0(-1.14%)
Currency In USD
| Market Cap | 3.77M |
| Enterprise Value | -1.77M |
| P/E Ratio | -0.49 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.69 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.29 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -3.12 |
| Return On Equity | -2.81 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.99M |
| Net Income | -13.56M |
| Diluted EPS | -10.36 |
| Total Cash | 1.69M |
| Total Cash/Share | 0.64 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.98 |
| Book Value Per Share | 0.97 |
| 52-Week Change | -58.9 |
| 52-Week High | 19.63 |
| 52-Week Low | 1.76 |
| Moving Average 50 Days | 2.77 |
| Moving Average 200 Days | 4.61 |
| Average Volume | 56,477 |
| Shares Outstanding | 2.27M |
| % Held by Institutions | 4.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | December 17, 2025 |